Year: 2026
Type: article
Abstract: Mitochondria are not merely cellular powerhouses; they serve as dynamic regulators of key processes essential for cell survival. Beyond ATP production, mitochondria are central to redox homeostasis, cellular stress responses, innate immunity, cell division, differentiation, and apoptosis. Consequently, mitochondrial dysfunction is implicated in a wide range of diseases, particularly neurodegenerative disorders such as Parkinson’s disease. Mitoprotective activity of A. trabeculosa has been previously reported in a recent high-throughput screening from our lab. In a comprehensive chemical and biological investigation of Alnus trabeculosa, we isolated five diarylheptanoids, eight diarylheptanoid glycosides, and vanillic acid. Biological evaluation of the isolated diarylheptanoids and their glucosides using 6-hydroxydopamine (6-OHDA) to induce neurotoxicity in SH-SY5Y cells showed that several compounds exhibited potent mitoprotective activity, effectively attenuating cell death with apparent EC 50 values ranging from 3.84 µM to 19.95 µM. These compounds also mitigated the loss of mitochondrial membrane potential with apparent EC 50 values between 2.95 µM and 20.15 µM. These findings highlight the therapeutic potential of these A. trabeculosa- derived compounds as promising candidates for mitochondria-targeted drug development.
Source: Frontiers in Natural Products
Authors: Emmanuel A. Makinde(Conceptualization, Data curation, Investigation, Methodology, Validation, Writing – original draft, Writing – review & editing), Linlin Ma(Conceptualization, Investigation, Methodology, Supervision, Validation, Writing – review & editing), George D. Mellick(Conceptualization, Investigation, Methodology, Supervision, Validation, Writing – review & editing), Yunjiang Feng(Conceptualization, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Writing – review & editing)
Institution: Griffith University
Language: English
Subfield: Plant Science
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,353
OpenAlex ID: W7236416417
